Frontotemporal dementia encompasses a group of clinical syndromes defined
pathologically by degeneration of the frontal and temporal lobes. Historically, these …

Frontotemporal dementia (FTD) is a heterogeneous clinical, genetic, and neuropathological
disorder. Clinical diagnosis and prediction of neuropathological substrates are hampered by …

The term frontotemporal dementia (FTD) refers to a group of neurodegenerative disorders
that are associated with atrophy of the frontal and temporal lobes, and present clinically with …

Frontotemporal dementia (FTD) is a clinically and neuroanatomically heterogeneous
neurodegenerative disorder with multiple underlying genetic and pathological causes …

The term frontotemporal lobar degeneration (FTLD) refers to a group of neurodegenerative
disorders that target the frontal and temporal lobes. It accounts for approximately 10% of …

Neuroimaging has played an important role in the characterization of the frontotemporal
dementia (FTD) syndromes, demonstrating neurodegenerative signatures that can aid in the …

While recent advances in the development of neuroimaging and molecular biomarkers for
studying neurodegenerative conditions have revolutionized the field, dementia remains a …

Background Diagnosing frontotemporal dementia may be challenging. New methods for
analysis of regional brain atrophy patterns on magnetic resonance imaging (MRI) could add …

Frontotemporal dementias are a clinically, neuroanatomically, and pathologically diverse
group of diseases that collectively constitute an important cause of young-onset dementia …

The role of neuroimaging for the diagnosis of frontotemporal dementia (FTD) remains
controversial. The modern history of imaging in the study of FTD is outlined. Also, the …